Tumor markers for thyroid malignant disease
Tamura, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 2): 298-303
2011
ISSN/ISBN: 0047-1852 PMID: 21830558 Document Number: 654393
Document emailed within 1 workday
Related Documents
Reshad, K.; Suzuki, K.; Inui, K.; Takahashi, Y.; Umemiya, M.; Nakano, Y.; Sakamoto, M.; Takeuchi, Y.; Shimada, T. 1985: The sensitivity and specificity of tumor markers (CEA, ferritin, beta 2-MG, TPA, IAP, sialic acid) in malignant and non-malignant pulmonary diseases and their relation to smoking and sex Nihon Kyobu Shikkan Gakkai Zasshi 23(11): 1343-1350Slavnov, V.N.; Markov, V.V.; Kovalenko, A.E.; Kovpan, N.A.; Kvacheniuk, A.N. 1997: Tumor markers in the diagnosis of thyroid cancer Likars'ka Sprava 4: 31-34
Brasanac, D.; Jancić-Zgurics, M.; Janković, R.; Tatić, S. 1993: Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers Srpski Arhiv Za Celokupno Lekarstvo 121(3-7): 70-73
Banno, S.; Ueda, R. 2002: Tumor markers in malignant lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(1): 149-153
Mizukami, Y.; Nonomura, A.; Michigishi, T.; Noguchi, M.; Nakamura, S.; Hashimoto, T. 1993: Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes Anticancer Research 13(1): 267-271
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093
Hou, J.-X.; Yang, X.-Q.; Chen, C.; Jiang, Q.; Yang, G.-L.; Li, Y. 2011: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis Hepato-Gastroenterology 58(106): 632-636
Cui, W.; Lu, X.; Zheng, S.; Ma, Y.; Liu, X.; Zhang, W. 2012: The Use of a Combination of Ki-67, Galectin-3 And PTTG Can Distinguish the Benign And Malignant Thyroid Tumor Clinical Laboratory 58(5-6): 419-426
Paster, I.P.; Liutkevych, O.V.; Tron'ko, M.D. 2006: Estimation of frequency of the main clinical features in patients with malignant tumor of thyroid gland after radical operative intervention Klinichna Khirurhiia 8: 40-42
Przystasz, T.; Badowski, A.; Dumański, Z. 1979: Malignant teratoma of the thyroid gland in a patient with Hashimoto's disease Polski Przeglad Chirurgiczny 51(5): 511-515
Hurley, D.L.; Gharib, H. 1995: Thyroid nodular disease: is it toxic or nontoxic, malignant or benign? Geriatrics 50(6): 24-26; 29-31
De Micco, C.; Zoro, P.; Henry, J.F. 1994: Malignancy markers in the cytodiagnosis of thyroid nodules. Thyroid peroxidase Annales de Pathologie 14(6): 378-383
Khalifa, A.; Mady, E.A.; Abadeer, N.; Kamal, A. 1999: Differential tumor markers and hepatitis markers profile in liver tumors Anticancer Research 19(4a): 2495-2500
Muramatsu, T. 1988: Function of carbohydrate chains serving as tumor-markers and differentiation markers Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 79: 27-36
Nano, M.; Ricci, E.; Pecchio, F.; Rapellino, M.; Giaccone, M.; Molaschi, M. 1988: Relations between markers and immunological status in surgical patients. Tumor markers and immunity in surgery Minerva Medica 79(11): 943-946
Kaneda, H.; Hara, M.; Yamatani, K.; Takahashi, K.; Kamimura, T.; Sasaki, H. 1984: A case of primary malignant lymphoma in the thyroid gland arising from pre-existing Hashimoto's disease Gan no Rinsho. Japan Journal of Cancer Clinics 30(4): 373-377
J. Gilmour'; Blownlee, Y.; Foster, P.; Geekie, C.; Kelly, P.; Robeltson, S.; Wade, E.; H-Braun, B.; Staub, U.; Michel, G.; J.H. Lazarus and A.B. Parkes 2000: The Quantitative Measurement of Autoantibodies to Thyroglobulin and Thyroid Peroxidase by Automated Microparticle Based Immunoassays in Hashimoto's Disease, Graves' Disease and a Follow-Up Study on Postpartum Thyroid Disease Clinical Laboratory 46(1-2): 57-61
Colletta, G.; Cirafici, A.M.; Di Carlo, A. 1989: Dual effect of transforming growth factor beta on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers Cancer Research 49(13): 3457-3462
Kwaan, H.C. 1988: Tumor growth and metastases in malignant disease. A review Journal of Medicine 19(3-4): 179-191
Pohorski, A.; Laskowski, S.; Koppicz, M.; Ratajski, W. 1975: Malignant transformation of an abdominal tumor in a case of Recklinghausen's disease Wiadomosci Lekarskie 28(18): 1593-1595